Hubbry Logo
Tom FriedenTom FriedenMain
Open search
Tom Frieden
Community hub
Tom Frieden
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Tom Frieden
Tom Frieden
Tom Frieden
View on Wikipedia
from Wikipedia

Thomas R. Frieden (born December 7, 1960) is an American infectious disease and public health physician. He serves as president and CEO of Resolve to Save Lives, a global initiative working to prevent epidemics and cardiovascular disease. Launched in 2017 as a five-year initiative, it became an independent non-profit organization in 2022.[1][2][3][4][5]

Key Information

He was the director of the U.S. Centers for Disease Control and Prevention (CDC), and he was the administrator of the Agency for Toxic Substances and Disease Registry from 2009 to 2017,[6][7] appointed by President Barack Obama.[8]

As a commissioner of the New York City Department of Health and Mental Hygiene from 2002 to 2009 he came to some prominence for banning smoking in the city's restaurants as well as the serving of trans fat.[9]

Education

[edit]

Frieden was born and raised in New York City. His father, Julian Frieden, was chief of coronary care at Montefiore Hospital and New Rochelle Hospitals in New York.[10] Frieden attended Oberlin College graduating with a BA degree in philosophy in 1982.[11] He was a community organizer for the Center for Health Services at Vanderbilt University in 1982, before he started studying medicine at Columbia University College of Physicians and Surgeons and graduated with an MD degree in 1986. At the same time he attended Columbia University Mailman School of Public Health and obtained an MPH degree in 1986. He completed a residency in internal medicine at Columbia-Presbyterian Medical Center 1986–1989 followed by a one-year infectious diseases fellowship from 1989 to 1990 at Yale School of Medicine and Yale–New Haven Hospital.[12]

Career

[edit]

CDC, New York City Department of Health, WHO, 1990–2002

[edit]

From 1990 to 1992, Frieden worked as an Epidemic Intelligence Service officer assigned by CDC in New York City.[13][14][15] From 1992 to 1996,[16] he was assistant commissioner of health and director of the New York City Department of Health and Mental Hygiene, Bureau of Tuberculosis Control, fostering public awareness and helping to improve city, state and federal public funding for TB control.[17][18] The New York City epidemic was controlled rapidly, reducing overall incidence by nearly half and cutting multidrug-resistant tuberculosis by 80 percent.[19] The city's program became a model for tuberculosis control nationally and globally.[20][21]

From 1995 to 2001, Frieden worked as a technical advisor for the World Bank, health and population offices.[12] From 1996 to 2002, Frieden worked in India, as a medical officer for the World Health Organization on loan from the CDC. He supported Dr. Khatri and the government of India to implement the Revised National Tuberculosis Control Program.[22][23][24][25] In 2001 he was offered the post of Commissioner of Health of New York City. Before his departure at the end of 2001, the programme had treated around 800,000 million patients.[26] Rapid expansion occurred after his departure and the program's 2008 status report estimated that the nationwide program resulted in 8 million treatments and 1.4 million lives saved.[27] While in India, Frieden and Khatri worked to establish a network of Indian physicians to help India's state and local governments implement the program[28] and helped the Tuberculosis Research Center in Chennai, India, establish a program to monitor the impact of tuberculosis control services.[29][30]

New York City Health Commissioner, 2002 to 2009

[edit]

Frieden served as Commissioner of Health of the City of New York from 2002 to 2009. At the time of his appointment, the agency employed 6,000 staff and had an annual budget of $1.6 billion.[31]: 8  During Frieden's tenure as Commissioner, the Health Department expanded the collection and use of epidemiological data,[32] launching an annual Community Health Survey[33] and the nation's first community-based Health and Nutrition Examination Survey.[34][35]

New York City's life expectancy at birth increased by 3 years, from 77.9 years in 2001 to 80.9 years in 2010, a faster increase than the national average.[36]

Tobacco control, 2002 onward

[edit]

Upon his appointment as Commissioner of Health, Frieden made tobacco control a priority,[37] resulting in a rapid decline[38] after a decade of no change in smoking rates. Frieden established a system to monitor the city's smoking rates, and worked with New York City Mayor Michael R. Bloomberg to increase tobacco taxes, ban smoking in workplaces including restaurants and bars, and run aggressive anti-tobacco ads and help smokers quit.[39] The program reduced smoking prevalence among New York City adults from 21% in 2002 to 17% in 2007 which represented 300,000 fewer smokers.[38][40] Smoking prevalence among New York City teens declined even more sharply, from 17.6% in 2001 to 8.5% in 2007, which was less than half the national rate.[41] The workplace smoking ban prompted spirited debate before the New York City Council passed it and Mayor Bloomberg signed it into law.[42] Over time, the measure gained broad acceptance by the public and business community in New York City.[43][44] New York City's 2003 workplace smoking ban followed that of California in 1994. Frieden supported increased cigarette taxes as a means of reducing smoking and preventing teens from starting, saying "tobacco taxes are the most effective way to reduce tobacco use."[31]: 23–38  He supported the 62-cent federal tax on each cigarette pack sold in the United States, introduced in April 2009.[45] One side effect of the increased taxes on tobacco in New York was a large increase in cigarette smuggling into the state from other states with much lower taxes, such as Virginia. The Tax Foundation estimated that "60.9% of cigarettes sold in New York State are smuggled in from other states".[46] In addition, some New Yorkers began to make their own cigarettes, and tobacco trucks were even hijacked. A 2009 Justice Department study found that "The incentive to profit by evading payment of taxes rises with each tax rate hike imposed by federal, state, and local governments".[47]

[edit]

Frieden introduced the city's first comprehensive health policy, Take Care New York, which targeted ten leading causes of preventable illness and death for public and personal action.[48][49] By 2007, New York City had made measurable progress in eight of the ten priority areas.[50]

As Health Commissioner, Frieden sought to fight HIV and AIDS with public health principles used successfully to control other communicable diseases.[51] A very controversial aspect was the proposal to eliminate separate written consent for HIV testing. He believed the measure would encourage physicians to offer HIV tests during routine medical care,[52] as the CDC recommended.[53] Some community and civil liberties advocates fought this legislation, arguing it would undermine patients' rights and lead eventually to forced HIV testing.[54][55] In 2010, New York State passed a new law that eased the requirement for separate written consent in some circumstances.[56] Frieden's perspective is now widely accepted,[57] and on February 14, 2007, the New York City Department of Health and Mental Hygiene introduced the NYC Condom,[58][59] prompting Catholic League president Bill Donohue to respond, "What's next? The city's own brand of clean syringes?"[60] More than 36 million condoms were given away by the program in 2007.[61]

Diabetes test result reporting, 2006

[edit]

Frieden worked to raise awareness about diabetes in New York City, particularly among pregnant women,[62] and established an involuntary, non-disclosed hemoglobin A1C diabetes registry which tracks patients' blood sugar control over several months and reports the information to treating physicians to help them provide better care.[63][64]

The New York City Board of Health's decision[65] to require laboratories to report A1C test results generated a heated debate among civil libertarians, who viewed it as a violation of medical privacy and an intrusion into the doctor-patient relationship. Although patients may elect not to receive information from the program, there is no provision enabling patients to opt out of having their glycemic control data entered in the database.[66][67]

Transfat plan, 2006

[edit]

In September 2006, the city proposed to restrict trans fat served in New York restaurants.[68][69][70] New York City's trans fat ban followed mandatory labeling of trans fat by the Food and Drug Administration (FDA), was credited with saving lives and preceded by more than a decade the FDA's action to ban trans fat from food throughout the United States.[71]

CDC Director, Agency for Toxic Substances and Disease Registry Administrator, 2009–2017

[edit]

In May 2009, the White House and the Department of Health and Human Services named Frieden director of the Centers for Disease Control and Prevention and administrator of the Agency for Toxic Substances and Disease Registry; positions he assumed in June 2009, from the acting head Richard E. Besser.[72][6][7] Frieden resigned effective January 20, 2017.[7][73]

On announcing Frieden's appointment, President Obama called him "an expert in preparedness and response to health emergencies" who in seven years as New York City's health commissioner was "at the forefront of the fight against heart disease, cancer and obesity, infectious diseases such as tuberculosis and AIDS, and in the establishment of electronic health records."[8]

Ebola epidemic, 2014

[edit]
Frieden is decontaminated after visiting Ebola treatment unit in Liberia, August 2014

Frieden was prominently involved in the US and global response to the West African outbreak of Ebola. His visits to West Africa beginning in August 2014 and a September 2014 CDC analysis projecting that the Ebola epidemic could increase exponentially to infect more than 1 million people within four months[74] prompted him to press for an international surge response.[75] At the peak of the response, CDC maintained approximately 200 staff per day in West Africa and about 400 staff per day at its Atlanta headquarters; overall, about 1,900 CDC staff deployed to international and U.S. locations for about 110,000 total work days, and more than 4,000 CDC staff worked as part of the response.[76] After the first U.S. healthcare worker became infected with Ebola, CDC Director Thomas Frieden initially attributed it to a “breach in protocol,” but later acknowledged that investigators had “not identified any personal protective equipment (PPE) or infection control problems” responsible for the transmission,[77] and early messaging suggested that U.S. hospitals were adequately prepared for Ebola cases, a premise later criticized as overly optimistic.[78] The CDC was criticized for not immediately deploying an Ebola response team to Dallas, instead waiting until two days after Thomas Duncan’s admission and after laboratory confirmation of Ebola—this forced the inexperienced local team led by the mayor with no medical training to start the outbreak investigation[79] The Dallas case also revealed deficiencies in hospital preparedness and response capabilities. Ebola was not initially considered during the patient’s first emergency department visit, despite a fever and travel history from Liberia.[80][81] Critics further described the CDC’s infection-control guidelines as overly complex and difficult to implement in real-world hospital settings.[82] Exacerbating the situation, the Ebola crisis came on the heels of public criticism over CDC laboratory protocol lapses, including exposure incidents involving anthrax and smallpox among CDC scientists.[83] In a Congressional hearing in October 2014, Frieden was asked about his handling of the Ebola crisis after the disease had spread to two nurses from a patient in the US.[84] The day prior, Rep. Tom Marino (R-PA) had called for Frieden's resignation,[85] though others rallied to his defense.[86][87]

During Frieden’s tenure as CDC director, he identified “winnable battles”: tobacco use, teen pregnancy, HIV, healthcare-associated infections, nutrition and physical activity, and motor vehicle fatalities. Tobacco use decreased from 21% to 15%, teen pregnancy decreased, three of four targeted healthcare-associated infections decreased, one of two targeted foodborne infections decreased, breastfeeding at six months increased, and motor vehicle fatalities decreased. There was little or no progress reducing childhood obesity, catheter-associated urinary tract infections, or foodborne illness from Salmonella.[88] A Public Health Associate Program trained new public health specialists at state and local health departments.[89] Frieden called antimicrobial resistance “a threat to our economic stability and to modern medicine” [90] and drew attention to the overprescription of and increase in deaths from opioids[91] and oversaw a controversial CDC on prescribing practices.[92] The guideline was criticized for resulting in excessive restrictions on opioid prescribing; critiques were at least in part the result of opioid industry influence.[93] While director, drug overdose deaths in the U.S. rose significantly—from approximately 37,000 deaths in 2009 to around 63,600 in 2016, and about 70,200 in 2017 (though Frieden resigned early that year)--during his tenure approximately 370,000 to 400,000 Americans died from drug overdoses.

Non-profit leadership: Resolve to Save Lives

[edit]

In 2017, Frieden started leading an initiative called "Resolve to Save Lives" to prevent cardiovascular disease and epidemics.[94] The effort is funded by Bloomberg Philanthropies, the Chan Zuckerberg Initiative and the Bill & Melinda Gates Foundation.[95] Proposed strategies are being tried in various countries [96][97] including India,[98] China,[99] and Nigeria.[100] These strategies include working with the World Health Organization to eliminate trans fat,[101][102][103] reduce salt consumption worldwide.[104][105] and scale up treatment for high blood pressure. The salt reduction effort is controversial, with some scientists stating that lower sodium intake may harm some people.[106][107] The initiative also works to make countries better prepared for epidemics and have funding to fill preparedness gaps.[108][109][110]

Frieden appeared widely in US and global media during the COVID-19 pandemic and became a leading voice sharing science-based analysis of the pandemic via Twitter, while advocating for increased pandemic preparedness, vaccine equity, and stronger public health systems.[111][112] He appeared on many news shows including The Today Show, CBS News, CNN, PBS, Good Morning America, BBC World News, MSNBC,[113][114][115][116][117][118] and was quoted in The New York Times,[119] The Wall Street Journal,[120] The Washington Post,[121] STAT,[122] The Hill,[123] and published articles in leading outlets including on pandemic preparedness,[124] global health security,[125] primary health care,[126] and cardiovascular health.[127] Frieden's op-eds on the pandemic were published in The New York Times,[128] The Wall Street Journal,[124] The Washington Post,[112] and Foreign Affairs.[129]

Frieden argued against both broad-based lockdowns [130] and school closures [131] and supported mask use,[132] selective indoor closures when hospitals were overwhelmed pre-vaccine, and COVID-19 vaccination.[133] In March 2020, he warned that COVID-19 could kill one million Americans;[134] the U.S. death toll exceeded one million by 2022.[135]

Frieden co-authored a commentary with Former CDC Directors Jeffrey Koplan, David Satcher, Julie Gerberding, and Richard Besser calling for public health to lead the response to the pandemic, and for a reform of the CDC and US public health system.[136][137] Frieden identified CDC errors during the COVID-19 pandemic and joined other former directors to support a more robust CDC [138] and resist calls to dismantle the agency.[139] He suggested ways forward to rebuild trust in and effectiveness of public health, including the need to improve disease tracking systems, minimize mandates, and make progress on issues that matter to communities.[140] He has argued that the main lessons of the COVID-19 pandemic are the need for a public health renaissance, robust primary health care, and resilient individuals and communities.[141]

In April 2022, Frieden led the transition of Resolve to Save Lives to become an independent, U.S.-based not-for-profit organization after five years of rapid expansion incubated at Vital Strategies.[5]

Working with the World Health Organization, Resolve to Save Lives partnered with countries to expand trans fat bans to more than 40% of the world population.[5][142][143] It is estimated that these bans will save millions of lives.[144][145] Frieden has noted that cardiovascular disease kills far more people than Covid, and called for more action to reduce its three leading preventable causes: tobacco use, hypertension, and air pollution.[146] Resolve to Save Lives supports treatment of hypertension and diabetes,[147] and created Simple, an app to improve care of patient care.[148] The organization has highlighted unsung successes in public health, including Epidemics That Didn't Happen,[149] and proposed a global target[150] to reduce the risk of the next pandemic, 7-1-7:[151] 7 days to find every outbreak, 1 day to report it to public health, and 7 days to have all essential control measures in place.[152][153] The 7-1-7 target has been adopted by the World Health Organization [154] and more than two dozen countries [155] and can accelerate improvements in preparedness.[156]

Arrest and charge for forcible touching, sex abuse, and harassment (Brooklyn)

[edit]

Dr. Tom Frieden surrendered to Brooklyn Special Victim's Unit August 24, 2018 to face charges that he groped a woman.[157][158] Frieden was charged with forcible touching, sex abuse and harassment and was scheduled to appear in court in Brooklyn for his arraignment [1]. According to sources, Frieden grabbed the victim, whom he has known for two decades, as they, along with others, were leaving his home.[159] A representative of the Brooklyn District Attorney’s Office communicated to the press that Frieden was arraigned and released without bail.[159] The judge also issued an order of protection that prevented him from having contact with the victim. New York State penal law classifies forcible touching as a class A misdemeanor that involves a person “intentionally, and for no legitimate purpose” forcibly touching “the sexual or other intimate parts of another person for the purpose of degrading or abusing such person, or for the purpose of gratifying the actor’s sexual desire. Examples of forcible touching are squeezing, grabbing, or pinching, and, according to the Rape, Abuse & Incest National Network (RAINN), the penalty for a conviction is up to one year in prison. In Brooklyn Criminal Court on June 4, 2019, Frieden plead guilty to disorderly conduct News. In return, Frieden avoided jail time, and the criminal charges were dropped.[160] As part of the plea deal, Frieden also accepted an order to stay away from the woman — a long time family friend-- for a year. The plea deal included expungement of his record at the end of a year if he had no further violations.[160]

Public Health Concepts and Advocacy

[edit]

Frieden developed the "Public Health Impact Pyramid," an influential framework that organizes public health interventions from societal changes to individual counseling based on their population impact and effort needed.[161][162] His work in public health analytics has emphasized the importance of using multiple forms of evidence beyond randomized controlled trials. Building on work by Nobel Laureate Angus Deaton and others, he has argued that although trials provide valuable evidence, other study designs may better answer some public health questions.[163] In global health policy, Frieden has advocated for restructuring World Bank health spending,[164] eliminating cholera as both an immediate priority and preparation for future pandemics,[165] and developing epidemic-ready primary health care systems.[166] He has also called for more aggressive responses to emerging threats such as avian influenza.[167]

Personal life

[edit]

Frieden has two children,[168][169] and his brother, Jeff Frieden, is a political scientist.[170] Frieden is Jewish.

In 2017, Frieden was awarded an honorary Sc.D. degree from New York University.[171]

In 2018, Frieden faced misdemeanor charges of forcible touching, third-degree sexual abuse and second-degree harassment.[172][173] All charges were dropped. He pled guilty to disorderly conduct.[174][175][176]

Publications

[edit]
logo
Scholia has a profile for Tom Frieden (Q7815868).

Frieden has published more than 200 peer reviewed articles.

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Tom Frieden

View on Grokipedia
from Grokipedia
Thomas R. Frieden is an American physician trained in , infectious diseases, , and , who has held senior leadership roles in government health agencies and non-profit organizations focused on disease prevention. He directed the Centers for Disease Control and Prevention (CDC) from 2009 to 2017, the second-longest tenure in the agency's history, during which he oversaw responses to global health emergencies including the 2014-2016 Ebola outbreak. Prior to the CDC, Frieden served as New York City Health Commissioner from 2002 to 2009, implementing data-driven policies that reduced smoking prevalence by over 350,000 people, banned trans fats in restaurants, and mandated calorie labeling in chain eateries. Earlier in his career, Frieden led New York City's tuberculosis control efforts from 1992 to 1996, documenting and curbing the largest outbreak of in the United States, which reduced such cases by 80 percent. He holds an MD and MPH from and advanced training from Yale and other institutions. Since 2017, Frieden has served as president and CEO of Resolve to Save Lives, a global initiative partnering with governments to prevent epidemics and cardiovascular diseases through policy interventions projected to avert millions of deaths. Frieden's career has been marked by emphasis on and regulatory measures to address non-communicable and infectious threats, though his approaches, such as soda size limits in , drew criticism for overreach into personal choices. In 2018, he was arrested in on charges of third-degree , forcible touching, and following an allegation of a woman; he later pleaded guilty to a reduced charge of , with the original charges dismissed under a conditional discharge that sealed the record after one year of compliance.

Early Life and Education

Family Background and Upbringing

Thomas Frieden was born in , , and raised in Westchester County. His father, a cardiologist who had served as an Army veteran in and later devoted his career to , emphasized the importance of punctuality and hard work during Frieden's upbringing. Frieden's mother held a in Russian history. The family maintained a mostly secular household in Westchester. Frieden later credited an early conversation with his father for sparking his interest in public health.62122-8/fulltext)

Academic Training and Early Influences

Frieden earned a degree in philosophy from in 1982, where he double-majored in philosophy and pre-medicine and wrote an honors thesis on . His undergraduate studies emphasized analytical thinking, which later informed his evidence-based approach to policy. In 1986, Frieden received both his and Master of Public Health degrees from Columbia University's College of Physicians and Surgeons and Mailman School of , respectively. During , he was influenced by Berton Roueché's The Medical Detectives, a collection of case studies highlighting epidemiological detective work, which reinforced his interest in applying scientific investigation to disease control. Following graduation, Frieden completed residency training in and a fellowship in infectious diseases at Yale-New Haven Hospital. A primary early influence was his father, a cardiologist known for his patient-centered practice and philosophy of directly aiding individuals in need, which shaped Frieden's commitment to clinical excellence and . This paternal example emphasized hands-on medical care over abstract theory, aligning with Frieden's subsequent focus on practical, data-driven strategies to address population-level health threats.

Early Career in Public Health

Roles at CDC, WHO, and NYC Health Department (1990–2002)

Frieden joined the Centers for Disease Control and Prevention (CDC) in 1990 as an (EIS) officer, a two-year training program focused on applied and outbreak investigations, with his assignment based in . During this period, he conducted field investigations into infectious disease outbreaks, including and , contributing to rapid response efforts in urban settings. From 1992 to 1996, Frieden remained in , assigned by the CDC to the New York City Department of Health's Bureau of Tuberculosis Control. In this role, he led initiatives to combat (MDR-TB), implementing directly observed therapy and infection control measures that reduced MDR-TB cases by approximately 80 percent in the city. These efforts emphasized systematic patient tracking, treatment adherence, and hospital protocols to limit transmission, marking early applications of his focus on evidence-based interventions for infectious diseases. In 1996, Frieden transitioned to an assignment with the World Health Organization (WHO) in India, supported by the CDC, serving as Medical Officer for Tuberculosis Control until 2002. He assisted in developing and scaling India's Revised National Tuberculosis Control Programme (RNTCP), which adopted WHO's Directly Observed Treatment, Short-course (DOTS) strategy to enhance diagnosis, treatment, and case detection nationwide. Under his guidance, the program rapidly expanded to cover the entire country by 2006, treating over 10 million patients and averting nearly 3 million deaths through improved microscopy, drug supply chains, and community outreach. Frieden's work prioritized data-driven adjustments, such as rigorous patient outcome reviews, to address high-burden settings where tuberculosis mortality exceeded 400,000 annually prior to interventions.

Focus on Infectious Disease Control, Including Tuberculosis

Frieden's initial involvement in infectious disease control began as an Epidemic Intelligence Service (EIS) officer with the Centers for Disease Control and Prevention (CDC) from 1990 to 1992, during which he was assigned to New York City and conducted field investigations into outbreaks of drug-resistant tuberculosis, measles, and rubella. These efforts emphasized rapid epidemiologic assessment and containment measures to curb transmission in urban settings with high-density populations. From 1992 to 1996, Frieden directed the Bureau of Tuberculosis Control, addressing what was then the largest outbreak of (MDR-TB) in the United States. Under his leadership, the program implemented directly observed , enhanced case detection through expanded screening, and improved treatment adherence protocols, resulting in a more than 50% reduction in overall cases and an over 80% decline in MDR-TB cases citywide. These outcomes transformed New York City's approach into a replicable model for urban TB management, prioritizing empirical monitoring of treatment efficacy and resistance patterns over less rigorous historical methods. Subsequently, from 1996 to 2002, Frieden served as a medical officer and advisor for the (WHO) in , focusing on scaling the (DOTS) strategy amid one of the world's highest TB burdens. He contributed to policy reforms that accelerated DOTS implementation, integrating government commitment, standardized diagnostics, and supervised short-course , which expanded coverage nationwide and positioned as accounting for more than half of global DOTS patients in 2000 and 2001. Frieden co-authored analyses documenting this expansion, highlighting causal factors like decentralized training of health workers and improvements that boosted cure rates above 85% in covered areas. This work underscored the efficacy of evidence-based adherence strategies in resource-limited settings, though challenges persisted in achieving universal coverage due to infrastructural constraints.

Tenure as New York City Health Commissioner

Tobacco Control and Smoking Reduction Initiatives

During his tenure as New York City Health Commissioner from 2002 to 2009, Thomas Frieden prioritized as a core strategy to address the leading preventable , implementing measures aligned with evidence from epidemiological studies showing that higher prices and smoke-free environments reduce initiation and increase cessation rates. Key initiatives included advocating for the of 2002, signed into law on December 30, 2002, which prohibited smoking in virtually all indoor workplaces, including restaurants and bars, to protect nonsmokers from exposure documented to cause and . Frieden also supported substantial increases in cigarette excise taxes, such as the city's portion rising to $1.50 per pack by 2002, making less affordable and leveraging price elasticity to deter youth uptake and prompt quitting among price-sensitive adults. These policies were complemented by enhanced , with Frieden establishing systems to track smoking prevalence through annual surveys, revealing baseline adult rates of 21.6% in 2002 and enabling targeted interventions like free distribution. The combined approach yielded measurable declines: adult prevalence fell 11% from 21.6% in 2002 to 19.2% in 2003, equating to approximately 140,000 fewer smokers, with further reductions to 18.4% by 2004 across demographic groups including socioeconomic strata. By 2008, an estimated 300,000 fewer residents smoked compared to pre-initiative levels, correlating with projections of over 100,000 averted premature deaths from tobacco-related diseases like heart disease and cancer. Longer-term data under Frieden's framework showed sustained impact, with adult rates declining 28% from 2002 to 2012 and average daily consumption among smokers dropping from 14.6 to 11.8 cigarettes per day by 2012, effects attributable to the initial tax hikes and bans disrupting social acceptability of . While critics labeled the restrictions paternalistic, empirical outcomes from peer-reviewed analyses affirmed their efficacy without evidence of economic harm to sectors, as revenue in restaurants and bars remained stable or increased post-ban due to cleaner environments attracting nonsmokers. Frieden's emphasis on data-driven , including fines for violations, reinforced compliance and positioned New York City's model as influential for national and global efforts.

HIV Testing Policy Changes and Privacy Debates

During his tenure as New York City Health Commissioner from 2002 to 2009, Thomas Frieden advocated for shifting testing from an opt-in model requiring separate written and mandatory counseling to a routine approach integrated into standard medical care. He argued that the existing requirements, unique to compared to other infectious diseases, created significant barriers, resulting in low testing rates and an estimated 30% of -positive individuals in remaining undiagnosed as of 2005, facilitating unknowing transmission. Frieden's proposals, first formally pushed in December 2005, sought to eliminate written in favor of verbal notification and options, revise pre- and post-test counseling to be less prescriptive, and enhance partner notification protocols, aligning with emerging CDC guidelines recommending routine screening for adults aged 13-64 without separate . These changes were implemented temporarily through emergency regulations in 2005, allowing expanded testing in high-prevalence areas, but Frieden lobbied for permanent statutory amendments to New York state law, which at the time mandated distinct written consent forms and segregated HIV testing from routine blood work. By 2006, he proposed tracking HIV patients' treatment outcomes akin to tuberculosis surveillance, including access to additional medical data for public health officials to monitor adherence and reduce community spread. Supporters, including Frieden, contended that destigmatizing HIV testing as "exceptional" would normalize it, potentially increasing diagnosis rates by 20-30% based on pilot programs in other settings, while preserving patient autonomy through opt-out refusals without penalties. However, implementation faced delays due to state-level resistance, with full elimination of written consent not occurring until 2010 in New York, post-Frieden's departure. The policy shifts sparked intense privacy debates, with critics from HIV advocacy groups and civil liberties organizations, such as the ACLU and NYCLU, accusing Frieden of undermining and risking coerced testing under the guise of routine care. They argued that removing written safeguards could lead to inadvertent disclosures, exacerbate stigma in vulnerable populations, and enable unauthorized —citing emergency rules that reportedly gathered extra -related medical information without explicit patient approval. In May , activists filed legal challenges demanding the state halt these practices, claiming they violated privacy protections established during the AIDS crisis to prevent . Frieden countered that privacy concerns were overstated, as models maintained refusal rights and that the greater risk stemmed from undetected cases enabling exponential transmission, supported by epidemiological data showing late diagnoses correlated with 7-10 times higher mortality. Despite opposition, Frieden's framework influenced national discourse, contributing to the CDC's revised guidelines and later state adoptions, though detractors maintained it prioritized aggregate risk reduction over individual rights without robust evidence of net benefits outweighing autonomy erosions.

Interventions on Trans Fats, Diabetes Reporting, and Chronic Diseases

During his tenure as New York City Health Commissioner from 2002 to 2009, Thomas Frieden spearheaded the city's first major municipal ban on artificial trans fats in restaurant foods, targeting their established role in elevating risks of coronary heart disease through increased cholesterol and decreased cholesterol. In September 2006, Frieden announced the proposal to prohibit the use of partially hydrogenated oils containing s in frying and baking, framing them as a preventable contributor to cardiovascular mortality without nutritional necessity. The New York City Board of Health unanimously approved the regulation on December 5, 2006, implementing a phased approach: restaurants could no longer use frying fats or spreads exceeding 0.5 grams of per serving starting July 2007, with a full prohibition on all artificial s by July 2008. Frieden emphasized the evidence from epidemiological studies linking consumption to higher incidences of heart attacks and strokes, justifying the measure despite industry opposition citing compliance costs. Compliance monitoring involved inspections revealing widespread substitution with alternatives like , though long-term population-level reductions in intake were later associated with decreased cardiovascular event rates in affected jurisdictions. To address the rising prevalence of —a affecting an estimated 9% of New Yorkers by 2006, double the rate from a prior—Frieden directed the implementation of mandatory laboratory reporting of elevated A1c levels, establishing the first U.S. population-based registry for tracking glycemic control among diagnosed individuals. Enacted in 2005, this system required clinical labs to submit A1c results exceeding 6.5% (indicative of ) or 5.7–6.4% () to the health department, enabling targeted outreach, provider feedback, and disparity analysis without direct patient notification to preserve privacy. Frieden argued the approach filled gaps in voluntary self-reporting, which underestimated uncontrolled cases contributing to complications like neuropathy and , and allowed for interventions such as mailed educational materials to high-risk neighborhoods. By 2007, the registry had captured data on over 300,000 individuals, facilitating evidence-based resource allocation amid racial and socioeconomic gradients in diabetes burden, though critics raised concerns over potential stigmatization despite anonymized aggregation. This initiative exemplified Frieden's emphasis on as a precursor to chronic , yielding insights into poor control rates (e.g., only 45% of cases below target A1c thresholds) that informed subsequent policy. These measures formed part of Frieden's broader strategy to combat non-communicable diseases, which accounted for over 80% of premature deaths in , prioritizing modifiable risk factors like diet and metabolic dysregulation over traditional infectious disease foci. The restriction directly aimed at reducing , a primary driver of chronic cardiovascular conditions, while diabetes reporting enhanced secondary prevention by identifying uncontrolled cases linked to higher hospitalization rates for related comorbidities such as and renal failure. Frieden integrated these into a "health impact pyramid" framework, advocating upstream regulatory actions for greater population efficacy compared to individual counseling, with evaluations showing correlated declines in biomarkers and improved diabetes surveillance coverage. However, outcomes depended on behavioral adaptations and supply chain shifts, with no immediate citywide reductions in or incidence attributable solely to these policies amid confounding factors like national trends.

Overall Impact, Achievements, and Critiques of Paternalistic Approaches

Frieden's tenure as New York City Health Commissioner from 2002 to 2009 emphasized regulatory interventions to curb noncommunicable diseases, often prioritizing population-level risk reduction over individual choice in areas with established causal links to morbidity, such as use and dietary fats. The 2003 Smoke-Free Air Act, banning in indoor public spaces including bars and restaurants, correlated with a decline in adult smoking prevalence from 21.5% in 2002 to 18.4% by 2004 and 14.8% by , representing over 300,000 fewer smokers citywide. exposure fell 47% as measured by salivary , and acute hospitalizations decreased by 8% statewide following similar bans, underscoring the policy's role in mitigating environmental harms from active . The ban on artificial trans fats in restaurant-prepared foods removed a proven promoter of cholesterol elevation and , with compliance achieved without altering food taste or variety; subsequent state-level analyses linked such restrictions to tangible drops in heart attacks and strokes, estimating 300 annual lives saved in NYC alone. These efforts extended to chronic disease surveillance and infectious disease detection, including the 2006 mandate for laboratories to report hemoglobin A1C results, creating the first U.S. population-based registry to monitor glycemic control among over 1 million affected residents. Policy reforms also promoted routine opt-out HIV testing in clinical settings, aiming to boost diagnosis rates amid stagnant prevalence; by streamlining consent, testing volumes increased, though long-term transmission impacts remained tied to broader adherence challenges. Frieden framed these as "strategic interventions for maximum health impact," drawing on epidemiological data to justify overrides of default behaviors where evidence showed net benefits in averting preventable deaths—smoking alone causing over 10,000 annual NYC fatalities during his tenure. Critiques portrayed these measures as exemplifying , where government authority expanded into private lifestyle domains under the rationale of collective welfare, potentially eroding autonomy without proportional gains. The registry drew objections for compelling physician reporting, which privacy advocates argued infringed on for a noncommunicable condition, yielding surveillance data but unproven direct improvements in control rates or outcomes. testing shifts faced resistance from groups, who highlighted weakened as risking and stigma, particularly for marginalized populations, with claims of necessity based more on implementation barriers than rigorous privacy-benefit trade-offs. Observers noted that while bans on trans fats and leveraged clear causal of harm, analogous extensions to salt reduction or calorie postings invited skepticism on scalability and unintended effects, such as economic burdens on small businesses or displacement of risks without addressing root behavioral drivers like poverty-linked disparities. This approach, while data-driven, reflected a toward proactive state intervention in chronic risks, prompting debates on whether empirical successes justified precedents for further encroachments absent equivalent voluntary alternatives.

Leadership at the CDC

Appointment and Initial Priorities (2009–2017)

President Barack Obama nominated Thomas R. Frieden, M.D., M.P.H., as director of the Centers for Disease Control and Prevention (CDC) on May 15, 2009, selecting him for his experience leading public health initiatives in New York City, where he had reduced smoking rates and improved chronic disease outcomes. Frieden, who had previously worked at the CDC from 1990 to 2002 on infectious disease control, assumed the directorship in June 2009, succeeding Julie Gerberding. His appointment came amid ongoing responses to emerging threats, including the H1N1 influenza outbreak, which the agency had already begun addressing under interim leadership. Upon taking office, Frieden prioritized evidence-based strategies to address both infectious and non-communicable diseases, drawing from his "health impact pyramid" framework that emphasized upstream interventions like policy changes over individual treatments. He launched the "Winnable Battles" initiative in 2010, targeting six high-impact areas where measurable progress was feasible within one to four years: reducing use, improving nutrition, physical activity, and obesity rates; preventing healthcare-associated infections; reducing transmission; lowering teen pregnancy rates; and decreasing motor vehicle-related injuries. 32577-6/fulltext) This approach aimed to focus agency resources on achievable goals with broad partnerships, setting specific targets such as cutting adult prevalence by 4 percentage points by 2014. Frieden's early tenure emphasized integrating chronic disease prevention into the CDC's core mission, traditionally focused on infectious diseases and emergencies, by allocating resources to initiatives like expanded testing and cessation programs nationwide. He also advocated for stronger state and local capacities, arguing that fragmented systems hindered rapid responses, and pushed for data-driven metrics to evaluate interventions' . By 2016, the Winnable Battles framework reported progress, such as a 13% decline in teen births and reductions in hospital-acquired infections, though critics noted uneven implementation across states due to varying political support. Frieden served until January 2017, when he stepped down following the presidential transition.

Response to the 2014 Ebola Epidemic

As director of the CDC, Tom Frieden oversaw the agency's most extensive emergency response to date during the 2014–2016 West African epidemic, deploying approximately 4,000 staff members, including 1,897 to the affected region, to support outbreak control efforts such as , laboratory testing, and healthcare worker training. In the United States, the CDC issued guidelines for identifying potential Ebola cases among travelers, established screening protocols at five major airports monitoring around 29,000 individuals from October 2014 to December 2015, and designated 55 hospitals as specialized Ebola treatment centers by July 2015. Frieden emphasized that Ebola transmission required direct contact with bodily fluids, asserting low risk of widespread outbreaks if protocols were followed, as stated in an October 15, 2014, update where President Obama described the risk as "extraordinarily low." The first diagnosed U.S. case involved , who arrived from on September 20, 2014, sought care at Texas Health Presbyterian Hospital on September 25 but was sent home, and was readmitted on September 28 with confirmed on September 30. The CDC faced criticism for not dispatching a response team to until after lab confirmation, delaying support for the hospital. Duncan died on October 8, 2014, after which two nurses, Nina Pham and , who treated him contracted due to a breach in control protocols during high-risk procedures like . Frieden acknowledged, "Clearly there was a breach in protocol," and announced reviews of protective gear usage and training to address gaps in preparedness. Frieden opposed travel bans from affected countries, arguing on , , that closing borders would not effectively stop the and could hinder response efforts by limiting access for workers and supplies. This stance drew bipartisan amid rising public concern, with congressional hearings in questioning CDC guidance clarity and response efficacy after the nurse infections. Critics, including healthcare unions, highlighted inadequate protocols and over-reliance on hospitals without sufficient federal intervention, while Frieden maintained confidence in containment measures despite the incidents. In response to the Dallas incidents, Frieden directed the CDC to deploy rapid response teams to any future U.S. diagnosis within 24 hours and disseminated lessons learned nationwide to improve infection prevention. The U.S. ultimately recorded four cases—all travel-related or secondary to Duncan—with no further uncontrolled spread, though the episode exposed vulnerabilities in domestic preparedness and fueled debates over federal versus local responsibilities in crises.

Handling of Other Crises: Swine Flu, Zika, and

During Frieden's directorship, the CDC responded to the 2009 H1N1 influenza pandemic, which emerged in April 2009 and was declared a by Secretary on April 26. Frieden, who assumed the role of CDC director on June 8, 2009, oversaw rapid diagnostic test development, antiviral stockpiling, and production of a monovalent that matched the strain, leading to over 100 million doses distributed in the U.S. by early 2010 despite manufacturing delays. The response included extensive , with CDC laboratories confirming cases and monitoring antiviral resistance, contributing to an estimated 61.6 million illnesses, 274,000 hospitalizations, and 12,469 deaths in the U.S.—a milder outcome than seasonal flu in some demographics but disproportionately affecting younger people and pregnant women. While praised for mobilizing infrastructure and increasing among high-risk groups like pregnant women, the effort faced retrospective critique for initial projections of higher severity that may have fueled public anxiety, though empirical data supported proactive measures to avert worse spread. In response to the outbreak, which spread rapidly in the starting in 2015 and was linked to and Guillain-Barré syndrome, Frieden directed the CDC to activate its Operations Center on January 22, 2016. Key actions included issuing travel warnings for 46 countries, developing diagnostic tests confirmed by February 2016 to establish the virus's causal role in birth defects, and providing guidance for pregnant women, such as enhanced screening and contraception counseling in affected areas like , where Frieden visited in March 2016 to coordinate with local health officials. The CDC collaborated internationally, including with Colombia's Instituto Nacional de Salud on of pregnant women, enrolling over 10,000 participants to track outcomes, and requested $1.9 billion in funding, though congressional delays led Frieden to warn in 2016 that resources would deplete by September without action. The response emphasized mosquito and laboratory capacity-building, preventing widespread U.S. mainland transmission beyond localized and cases, but drew limited criticism for perceived slow federal funding allocation amid rising case counts exceeding 1,000 in U.S. territories by mid-2016. Frieden's CDC addressed the opioid epidemic, which saw prescription opioid-involved overdose deaths rise to 15,469 in 2010 and continue escalating, by issuing the "Guideline for Prescribing Opioids for Chronic Pain" on March 18, 2016, targeting non-cancer chronic pain in primary care settings. The 12 recommendations prioritized non-opioid therapies, immediate-release over extended-release formulations, maximum daily doses below 90 morphine milligram equivalents (MME) for most patients, and regular risk assessments via tools like prescription drug monitoring programs, drawing from systematic reviews showing opioids' modest benefits outweighed by risks of dependence, overdose, and fracture. Implemented amid a crisis with total drug overdose deaths reaching 52,404 in 2015, the guidelines correlated with a decline in opioid prescriptions from 258 million in 2012 to 191 million by 2017, but empirical evidence indicated persistent rises in overall overdose deaths to 70,237 by 2017, driven increasingly by illicit fentanyl rather than prescriptions. Criticisms emerged from medical groups like the American Medical Association, which in pre-release comments on January 12, 2016, warned of potential inflexibility leading to undertreatment, and later clinician reports documented misapplication as mandatory caps, resulting in forced dose reductions, patient abandonment, and elevated suicide risks among chronic pain sufferers, prompting CDC clarifications in 2017 that the guidance was not rigid and a 2022 update to mitigate harms.

Agency Reforms, Budget Challenges, and Broader Criticisms

Upon assuming leadership of the Centers for Disease Control and Prevention (CDC) in June 2009, Frieden implemented early organizational reforms aimed at streamlining operations by reducing management layers. In August 2009, he ordered the dismantling of a key structural component established under his predecessor, , which had created additional bureaucratic levels; this move sought to enhance efficiency and decision-making speed within the agency. The CDC encountered significant budget constraints during Frieden's tenure, exacerbated by federal fiscal policies. Between fiscal years 2010 and 2011, the agency's budget authority declined by $740 million, representing an 11% reduction and marking its lowest funding level in years. The 2013 sequestration further imposed across-the-board cuts, limiting programs—for instance, projections indicated roughly 2,050 fewer children vaccinated at a cost of $140,000—and prompting Frieden to advocate repeatedly in , with over 250 trips to secure bipartisan support and mitigate impacts on core functions like chronic disease prevention. To cope, the agency identified $100 million in administrative savings by fiscal year 2012, while its discretionary budget fell to $5.89 billion from $6.47 billion in 2010, shifting emphasis toward cost-effective chronic disease initiatives amid pinched resources. Broader criticisms of Frieden's leadership centered on laboratory safety lapses and perceived mission expansion. In June 2014, the CDC inadvertently shipped live to multiple U.S. laboratories, potentially exposing up to 84 personnel, followed by revelations of mishandled H5N1 samples that risked ; Frieden acknowledged these as part of a "pattern of unsafe practices" rather than isolated errors, leading him to impose a moratorium on transfers of select agents from high-containment labs. An independent review panel in 2015 concluded that the CDC was "on the way to losing credibility" due to inconsistent safety training, lack of requirements, and inadequate oversight, recommending mandatory external audits and enhanced protocols. Additionally, Frieden's public framing of as a epidemic—advocating for CDC research despite congressional restrictions under the —drew rebukes from critics who argued it diverted resources from infectious disease priorities and politicized the agency's scientific mandate, with some conservative outlets and lawmakers viewing it as advocacy for under the guise of .

Post-Government Roles

Founding and Leadership of Resolve to Save Lives (2017–Present)

In 2017, following his tenure as Director of the Centers for Control and Prevention (CDC), Tom Frieden founded Resolve to Save Lives, a global initiative housed within the Vital Strategies. Frieden established the organization to address leading causes of preventable death, drawing on his prior experience in control and chronic prevention during roles at the CDC and New York City Health Department. As its founding President and Chief Executive Officer, he has directed its operations from inception, emphasizing scalable interventions in low- and middle-income countries. Under Frieden's leadership, Resolve to Save Lives focuses on two primary pillars: preventing , which accounts for approximately 18 million annual deaths worldwide, and strengthening epidemic preparedness to avert outbreaks like or COVID-19. The initiative targets reducing 100 million deaths from heart disease through evidence-based strategies, including screening and management, dietary sodium reduction, trans fat elimination, and . For epidemics, it supports national action plans for , laboratory capacity, and rapid response systems, partnering with governments in over 50 countries. Frieden has advocated for integrating these efforts into national health systems, citing data from prior CDC programs showing that such targeted policies can achieve up to 40% reductions in hypertension-related mortality. The organization launched with $225 million in funding over five years, primarily from philanthropies including , the Bill & Melinda Gates Foundation, and Gates Philanthropy Partners. Under Frieden's stewardship, it has disbursed grants exceeding $3.4 million by 2021 for cardiovascular programs, such as management in and , and collaborated with entities like the on policy implementation. These efforts prioritize measurable outcomes, with Frieden reporting early successes in countries adopting salt reduction laws that lowered average sodium intake by 10-20% in pilot areas. Frieden's leadership has positioned Resolve to Save Lives as a bridge between philanthropic funding and government action, though scalability depends on sustained political will in recipient nations. He continues to serve in the CEO role as of 2025, overseeing expansions into U.S. advocacy and security financing.

Global Efforts on and Epidemic Prevention

Following his tenure at the CDC, Tom Frieden founded Resolve to Save Lives in as a initiative aimed at preventing (CVD) and enhancing preparedness, with a core goal of averting 100 million CVD deaths worldwide over 30 years through scalable, evidence-based interventions in low- and middle-income countries (LMICs). The organization's CVD efforts prioritize control, targeting an increase in global management from the baseline rate of 14% to 50%, alongside reductions in use, dietary salt intake, and other modifiable risk factors that contribute to the annual loss of approximately 18 million lives to heart disease and stroke. These strategies draw on protocols like the WHO's HEARTS technical package, which emphasizes simplified treatment regimens, team-based care, and access to affordable medications, implemented in with national governments and organizations such as the (PAHO) for initiatives like HEARTS in the Americas. Resolve has allocated resources including US$2.3 million in grants in to support heart health programs in LMICs, focusing on , supply chain improvements for essential drugs, and community-level screening to identify and treat early. Frieden has advocated for sodium reduction frameworks aligned with global standards, estimating that widespread adoption could prevent millions of CVD events by lowering population-level without relying on individual behavioral changes alone. In collaboration with the and NCD Alliance, the initiative promotes updated WHO guidelines, emphasizing fixed-dose combinations of generics to achieve cost-effective control rates exceeding 50% in pilot programs. Early implementations in regions like the have demonstrated feasibility, with data from routine clinical monitoring showing improved patient adherence and outcomes, though scalability depends on sustained government funding and supply reliability. On epidemic prevention, Resolve under Frieden's leadership seeks to build resilient health systems capable of rapid outbreak detection and containment, proposing the 7-1-7 target in 2021: detecting outbreaks within 7 days, notifying authorities within 1 day, and mounting a response within 7 days to halt transmission before epidemics escalate. The organization supported over 60 countries in strengthening COVID-19 responses through technical assistance on surveillance, contact tracing, and resource mobilization, while publishing reports highlighting successful pre-epidemic interventions that contained threats like Ebola and Zika without global spread. In Senegal, Resolve-backed advocacy via the Global Health Advocacy Incubator secured US$10.5 million in government funding over five years for emergency operations centers, including feasibility studies for crisis management projects that integrated into the national public investment program from 2021–2023. Partnerships, such as with PAHO in 2025 for the Americas, provide toolkits for training in risk communication, laboratory networks, and cross-border coordination, aiming to reduce the 14.7 million annual deaths from infectious diseases by enhancing early warning systems. These efforts underscore Frieden's emphasis on data-driven metrics for accountability, though challenges persist in resource-limited settings where political commitment and funding gaps hinder full realization.

Measurable Outcomes, Funding Sources, and Skepticism on Scalability

Resolve to Save Lives (RTSL) has reported supporting hypertension management programs reaching over 34 million people across multiple countries, focusing on team-based care, protocol-driven treatment intensification, and digital tracking tools to improve blood pressure control rates. In evaluations of implemented WHO-HEARTS hypertension programs in rural Bangladesh, blood pressure levels decreased significantly and hypertension control rates rose compared to usual care sites, with mean systolic blood pressure dropping by approximately 6 mmHg in intervention areas. For epidemic preparedness, RTSL has aided over 60 countries in enhancing outbreak detection and response systems, including during COVID-19, though specific mortality reductions attributable solely to these efforts remain unquantified in independent studies. The organization claims its policy advocacy has contributed to trans fat elimination regulations protecting nearly half the global population, or about 4 billion people, from industrially produced trans fats. RTSL's overarching goal is to prevent 100 million deaths by 2047 through scalable interventions like salt reduction, bans, and better , but direct attributions of deaths averted to its work are aspirational rather than empirically verified at scale. In 2023, the organization's revenue totaled $49.3 million, with expenses at $54.4 million, reflecting operations dependent on philanthropic grants. Funding primarily comes from Bloomberg Philanthropies and the Bill & Melinda Gates Foundation, which provided an initial $225 million commitment alongside Gates Philanthropy Partners (supported by the Chan Zuckerberg Initiative). Additional supporters include the Wellcome Trust, Skoll Foundation, and Open Philanthropy, enabling catalytic grants such as $2.3 million in 2019 for heart health initiatives in low- and middle-income countries. Skepticism regarding RTSL's scalability arises from implementation challenges, including inconsistent government adoption, clinical inertia in treatment protocols, and resource constraints in low-income settings that limit nationwide rollout beyond pilots. While interim analyses of programs show promise, historical precedents in similar initiatives indicate that pilot successes often fail to translate to sustained national impact without enduring local funding and political commitment, with rigorous, independent evaluations of long-term outcomes remaining sparse. Philanthropic dependency further raises questions about post-grant , as annual budgets in the tens of millions contrast sharply with the scale required to avert tens of millions of deaths amid rising global CVD burdens.

Criticisms of Public Health Policies: Overreach vs. Evidence-Based Wins

Frieden's tenure as New York City Health Commissioner (2002–2009) and CDC Director (2009–2017) featured aggressive interventions aimed at modifiable risk factors like tobacco use and poor diet, yielding measurable gains in some areas while drawing accusations of paternalism in others. Tobacco control policies, including NYC's comprehensive smoking ban enacted in 2003, correlated with a decline from 21.5% adult smoking prevalence in 2002 to 14% by 2008, averting an estimated 100,000 premature deaths through reduced exposure and cessation. Similarly, the 2006 trans fat ban in NYC restaurants led to near-elimination of artificial trans fats in prepared foods, aligning with epidemiological evidence linking trans fats to elevated cardiovascular risk, and served as a model for national FDA restrictions in 2015. At the CDC, Frieden prioritized evidence hierarchies—strongest for tobacco, where investments in state programs from 1999–2012 prevented over 1.3 million premature deaths nationwide by amplifying quit rates and reducing initiation. These outcomes rested on causal mechanisms like price increases and smoke-free laws, substantiated by longitudinal data showing dose-response reductions in heart attacks post-implementation. Obesity-focused policies under Frieden, however, faced sharper scrutiny for limited efficacy and governmental intrusion. The 2012 NYC soda portion cap (16 ounces maximum for sugary drinks over 16 fluid ounces), which Frieden endorsed as akin to regulation, was overturned by courts in 2013 amid public opposition—60% of New Yorkers viewed it unfavorably—and showed negligible impact on consumption or BMI trends in preliminary analyses, as consumers shifted to untaxed alternatives or larger purchases elsewhere. Frieden's advocacy for soda taxes, projected to reduce intake by 10–30% based on economic models, echoed excise successes but overlooked behavioral adaptations and industry circumvention, with critics labeling it "" overreach that prioritized coercion over education despite weaker causal evidence compared to bans. Proponents, including nutrition experts, defended such measures as necessary given soda's role in 10% of U.S. caloric intake and youth , yet post-policy data indicated only marginal declines attributable to interventions rather than broader trends. Critics, often from free-market perspectives, argued Frieden's "health in all policies" framework expanded beyond core competencies like infectious disease into regulation, risking backlash and inefficiency; for instance, mandatory calorie postings in chains (implemented 2008) informed consumers but did not significantly alter ordering patterns in randomized studies. At the CDC, initiatives consumed growing resources—budgets rose 20% for chronic disease programs by 2016—yet national rates stabilized rather than declined, prompting questions on whether evidence thresholds for intervention were consistently met versus politically driven expansions. Defenders countered that partial wins, like sustained NYC life expectancy gains of 3.1 years (87.2 to 81.9 infant mortality drop), validated a portfolio approach, though attribution debates persist amid socioeconomic factors. Overall, Frieden's record highlights tobacco's robust returns on regulatory investment versus diet's thornier path, where empirical weakens and overreach perceptions erode compliance.

Ebola Response Shortcomings and Accountability Questions

The CDC, under Director Tom Frieden, faced scrutiny for its handling of the first diagnosed case in the United States, involving , who arrived from on September 19, 2014, and was hospitalized in on September 28 after initial dismissal of symptoms. Frieden acknowledged that the agency should have deployed a hospital response more rapidly upon Duncan's admission, stating on October 15, 2014, that such teams would henceforth be sent immediately to any U.S. facility treating suspected cases to provide on-site guidance. Critics, including healthcare experts, argued that CDC protocols for (PPE) and infection control were insufficiently detailed and trained for non-specialized hospitals, contributing to secondary transmissions. Two nurses, Nina Pham and Amber Vinson, contracted while caring for Duncan—Pham diagnosed on October 12, 2014, and Vinson on October 15—prompting investigations into breaches during high-risk procedures like dialysis and respiratory . Frieden attributed the infections to a "protocol breach" in PPE usage, but this drew backlash from associations and experts who contended that CDC guidance lacked specificity on doffing procedures and environmental , exposing frontline workers despite compliance efforts. The Health Presbyterian also admitted diagnostic delays and communication errors in reporting Duncan's travel history, but congressional inquiries highlighted CDC's overreliance on voluntary hospital rather than mandatory standards. Overall, while the U.S. contained to four cases (including a New York physician exposed abroad), the incidents revealed gaps in domestic surge capacity and risk communication, with Frieden initially emphasizing low transmission risk in September 2014 before adjusting amid public concern. Accountability efforts centered on multiple congressional hearings where Frieden testified, including the House Energy and Commerce Committee's October 16, 2014, session on the U.S. response, during which lawmakers pressed on preparedness lapses and travel screening efficacy. Earlier, in an August 7, 2014, House Foreign Affairs Subcommittee hearing titled "Combating the Ebola Threat," Frieden outlined global containment strategies but faced questions on U.S. vulnerability. No formal disciplinary actions or resignation demands tied directly to resulted for Frieden, who remained in post until January 2017; instead, the response prompted internal CDC reforms, such as enhanced hospital toolkits and a 2016 MMWR review admitting needs for better operational support in outbreaks. Skeptics noted persistent questions over leadership focus, with some attributing shortcomings to bureaucratic inertia and prioritization of international aid over U.S. infrastructure upgrades.

2018 Arrest for Sexual Misconduct and Subsequent Resolution

On August 24, 2018, Thomas Frieden, former director of the Centers for Disease Control and Prevention (CDC), was arrested in , New York, following an accusation of non-consensual physical contact with a woman he knew. The complainant, a 55-year-old acquaintance described in some reports as a family friend, alleged that Frieden grabbed her buttocks without permission during a visit to his home in October 2017. Frieden turned himself in to authorities and was arraigned the same day in Kings County Criminal Court before Justice Michael Yavinsky on charges of forcible touching (a class A punishable by up to one year in jail), third-degree (another ), and second-degree (a violation). Frieden denied the specific allegations through a statement released by his attorney, asserting that they "do not reflect Dr. Frieden’s character or lifelong commitment to women’s rights and health," while expressing regret for any interactions that caused discomfort. The case proceeded under investigation by the New York City Police Department, with no immediate trial scheduled; Frieden was released on $1,000 bail and barred from contacting the complainant. The incident drew attention due to Frieden's prominent public health career, but reports indicated it stemmed from a private encounter rather than workplace misconduct. On June 4, 2019, Frieden resolved the case by pleading guilty to a single count of , a lesser violation carrying no upon completion of terms. The original charges of forcible touching, , and were dismissed as part of the plea agreement, approved by Court Justice Donald Leo Novillo. Frieden received a conditional discharge, requiring no further legal penalties beyond staying arrest-free for one year, after which the case would be sealed and dismissed; he served no jail time and issued no public comment on the plea. This outcome avoided a full , where evidentiary details such as statements or forensic were not publicly adjudicated.

Public Health Philosophy and Advocacy

Core Principles: Data-Driven Intervention and "Health in All Policies"

Frieden's approach to public health intervention centers on leveraging empirical to identify and prioritize evidence-based strategies that yield the greatest population-level benefits. During his tenure as New York City Health Commissioner from 2002 to 2009, he emphasized that effective requires to validate policies, such as surveillance systems tracking and trends to guide resource allocation and outbreak responses. This data-centric methodology extended to his CDC directorship (2009–2017), where he promoted the use of vital statistics, epidemiological modeling, and program evaluations to inform national priorities like and chronic disease prevention. In a 2016 reflection, Frieden described good as the "lifeblood of ," enabling officials to make decisions grounded in measurable outcomes rather than or alone. Central to his framework for data-driven intervention is the Health Impact Pyramid, which Frieden outlined in a 2010 American Journal of Public Health article. The pyramid conceptualizes interventions across five tiers, with the broadest impact at the base—addressing socioeconomic determinants like and through policy changes that require no individual-level contact—and narrowing to the apex of targeted counseling for high-risk individuals. Intermediate layers include community-wide changes to default behaviors (e.g., smoke-free laws making nonsmoking the norm), protective regulations (e.g., fluoridated water), and clinical interventions. Frieden argued that lower-tier efforts, supported by rigorous data on cost-effectiveness and reach, achieve disproportionate health gains compared to resource-intensive clinical or behavioral approaches, as evidenced by historical successes like reforms reducing mortality without direct patient interaction. This model critiques overreliance on individualized medicine, urging allocation based on intervention efficacy data from randomized trials and observational studies. The "Health in All Policies" principle, which Frieden implicitly operationalized through the pyramid's foundational emphasis on socioeconomic factors, advocates embedding and outcomes into decision-making across government sectors beyond traditional domains. In practice, this manifested in his initiatives, such as mandating calorie postings in chain restaurants (2008) to influence consumer behavior via and banning artificial trans fats in city eateries (2006), which required collaboration with urban planning, education, and economic regulators to alter environmental determinants of and . These efforts demonstrated causal links between non-health policies and health metrics, with data showing trans fat bans reducing population-level intake by over 50% without individual outreach. At Resolve to Save Lives, founded in , Frieden applies similar intersectoral tactics globally, partnering with governments to integrate cardiovascular risk reduction into fiscal and agricultural policies, underscoring that siloed health approaches fail to address upstream drivers like food systems and taxation. While HiAP as a formal has faced implementation challenges due to jurisdictional silos, Frieden's pyramid provides a data-validated rationale for its pursuit, prioritizing scalable, evidence-backed cross-sector reforms over fragmented clinical fixes.

Key Publications, Including "The Formula for Better Health" (2025)

Frieden has authored or co-authored more than 250 peer-reviewed articles, reports, and book chapters spanning infectious diseases such as tuberculosis, HIV/AIDS, antibiotic resistance, Ebola, and emerging pathogens, as well as broader public health strategies for epidemic prevention and noncommunicable disease control. These publications, often published in journals like the New England Journal of Medicine and The Lancet, have emphasized empirical evidence from field investigations, outbreak responses, and intervention trials to identify causal risk factors and scalable solutions, influencing global health policies during his tenure at the CDC and New York City Health Department. His work includes seminal contributions to tuberculosis control, such as studies on directly observed therapy and multidrug-resistant strains, which informed guidelines adopted in over 100 countries by the early 2000s. Frieden has also published on cardiovascular risk reduction, advocating for targeted interventions like taxation and sodium reformulation based on observational data linking policy changes to measurable declines in heart disease mortality rates. Additional outputs encompass op-eds and policy analyses in outlets including , , and , critiquing implementation gaps in U.S. systems during events like the . In September 2025, Frieden published The Formula for Better Health: How to Save Millions of Lives—Including Your Own (), a synthesis of four decades of epidemiological experience into a framework for addressing "invisible killers" such as , use, and infectious outbreaks. The book distills evidence-based principles—prioritizing high-impact, low-cost interventions like screening, treatment access, and behavioral nudges—drawing on real-world outcomes from programs that averted an estimated 50 million cardiovascular deaths globally since 2017 through Resolve to Save Lives initiatives. Frieden argues the formula's core elements, validated by randomized trials and cohort studies, extend to personal health choices, such as consistent management reducing risk by up to 40%, while warning against politicization that undermines scalability in diverse settings. The text critiques systemic barriers, including underfunding and regulatory delays, using case studies from U.S. cities and low-income nations to demonstrate causal pathways from policy adoption to mortality reductions.

Engagements on Global Health, U.S. Policy Critiques, and Partisan Debates

Frieden has advocated for sustained U.S. commitment to security, issuing a statement on January 20, 2025, condemning the withdrawal from the as rendering "Americans – and the world – less safe," emphasizing that the WHO remains "irreplaceable" for achievements like eradication and that reform demands engagement rather than abandonment. In a September 22, 2025, opinion piece, he highlighted risks from U.S. funding reductions to global programs such as and initiatives, projecting over 14 million preventable deaths by 2030 based on modeling from , and attributing an estimated 300,000 avoidable deaths already to diminished support. On , Frieden warned in an April 1, 2025, statement that CDC budget and staff cuts constitute a "recipe for disaster," impairing outbreak investigations—such as those for bird flu, dengue, and —via the Center and undermining tobacco prevention efforts through the Office on and Health, which he argued would primarily benefit the while elevating long-term healthcare costs. He has further critiqued broader erosion, including the resignation or firing of approximately 2,000 CDC personnel, elimination of programs like the Office of and Health that contributed to reducing U.S. adult prevalence from 42.6% in 1965 to 11.6% in 2022, and inability to assist state-level crises such as Wisconsin's response due to lost expertise. Frieden has engaged in debates framing public health amid political divides, participating on September 17, 2025, in the Hopkins Forum debate titled "Was COVID a Public Health Failure or Did Society Fail Public Health?", where he defended evidence-based responses against claims of institutional mismanagement and inconsistent guidance. Regarding the 2025 appointment of Robert F. Kennedy Jr. to influence health oversight, Frieden voiced apprehensions over proposals to fragment the CDC—limiting it to infectious diseases while sidelining chronic disease centers responsible for most U.S. mortality—and to reconstitute the Advisory Committee on Immunization Practices with members promoting debunked vaccine-autism links, contradicted by over 25 studies, potentially restricting vaccine access for half of American children and echoing hesitancy-fueled outbreaks like Samoa's 2019 measles epidemic that killed 83, predominantly children. While asserting that "public health should not be partisan" and crediting bipartisan successes under prior administrations, he has attributed recent unscientific shifts in COVID-19 vaccine recommendations to committee politicization, urging prioritization of data over ideology.

Personal Life

Family and Relationships

Tom Frieden has been married to Barbara Chang, his college sweetheart, since their time at . The couple resides in , New York, and shares the same address listed in associated with the 2017 incident leading to Frieden's 2018 . Frieden and Chang are parents to two sons. Details about the children, including their names and ages, have not been publicly disclosed, consistent with Frieden's practice of shielding his family from media attention. Frieden rarely speaks about his personal relationships in public forums, emphasizing instead his professional focus on during interviews and profiles. No records indicate a separation or divorce as of the latest available reports from 2018 onward.

Health Advocacy in Personal Context and Public Persona

Frieden's approach to health advocacy draws from familial influences, particularly his father, a cardiologist whose career emphasized and measurable patient outcomes. In a 2025 reflection, Frieden recounted his father's final words to him—"How would you know?"—asked amid the elder Frieden's battle with , challenging him to rigorously assess the effectiveness of interventions rather than assuming good intentions suffice. This query shaped Frieden's commitment to data verification in , extending to personal wellness by advising individuals to track whether lifestyle changes, such as exercise or diet modifications, demonstrably improve health markers like or levels. In his , Frieden has modeled through family-oriented physical pursuits, including a 275-mile cycling trip with his son in , which he credited to his father's profound influence on his values and habits. Such activities align with his broader promotion of exercise as a foundational preventive measure, independent of , to mitigate risks of cancer, heart disease, , , and depression. Publicly, Frieden cultivates a persona as an accessible, pragmatic advocate who bridges individual agency with systemic reform, often framing as "the closest thing we have to a miracle drug" or "wonder drug" for enhancing and . He urges practical steps like starting small with enjoyable exercises to overcome barriers, while critiquing overreliance on pharmaceuticals without complementary behavioral changes, as seen in his emphasis on balanced diets and routine monitoring to evade cardiovascular threats—the leading U.S. killer. This evidence-centric stance, rooted in personal ethos, positions him as a figure prioritizing verifiable personal accountability amid advocacy, though critics have questioned the coercive elements of his population-level initiatives.

References

  1. https://resolvetosavelives.org/about/team/tom-frieden/
  2. https://www.vagelos.columbia.edu/about-us/columbia-medicine-magazine/archives/fall-winter-2017/alumni-news-notes/alumni-profile-thomas-r-frieden86
  3. https://www.aspenideas.org/speakers/tom-frieden
  4. https://docs.house.gov/meetings/IF/IF02/20141118/102739/HHRG-113-IF02-Bio-FriedenT-20141118.pdf
  5. https://www.weforum.org/people/thomas-r-frieden/
  6. https://www.tedmed.com/person/thomas-frieden/
  7. https://www.linkedin.com/in/tom-frieden
  8. https://docs.house.gov/meetings/IF/IF00/20210322/111362/HHRG-117-IF00-Bio-FriedenT-20210322.pdf
  9. https://www.cidrap.umn.edu/public-health/choice-nycs-frieden-lead-cdc-wins-praise
  10. https://abcnews.go.com/US/cdc-director-pleads-guilty-groping-family-friend-jail/story?id=63478002
  11. https://www.statnews.com/2019/06/04/ex-cdc-chief-frieden-settles-sexual-harassment-charges/
  12. https://www.nytimes.com/2014/10/16/us/cdc-director-becomes-face-of-nations-worry-and-flawed-response.html
  13. https://www.timesofisrael.com/former-whiz-kid-now-ebolas-public-face-and-possible-scapegoat/
  14. https://forward.com/news/323915/tom-frieden/
  15. https://www.nbcnews.com/storyline/ebola-virus-outbreak/cdc-chief-tom-frieden-confronts-ebola-crisis-cool-collected-n175351
  16. https://www2.oberlin.edu/alummag/fall2006/life-on-the-cutting-edge.html
  17. https://docs.house.gov/meetings/IF/IF02/20140716/102479/HHRG-113-IF02-Bio-FriedenT-20140716.pdf
  18. https://www.gold-foundation.org/newsroom/blog/patients-must-be-vips/
  19. https://fortune.com/2025/09/21/tom-frieden-cdc-director-nyc-health-commissioner-words-from-father/
  20. https://ballotpedia.org/Tom_Frieden
  21. https://drtomfrieden.net/
  22. https://archive.cdc.gov/www_cdc_gov/globalhealth/countries/india/anniversary-report/program-area-tuberculosis.html
  23. https://www.tephinet.org/sites/default/files/content/resource/files/thomas_frieden.pdf
  24. https://pmc.ncbi.nlm.nih.gov/articles/PMC5791880/
  25. https://files.kff.org/attachment/speaker-biographies-where-do-we-stand-in-the-fight-against-ebola-a-conversation-with-cdc-director-tom-frieden
  26. https://obamawhitehouse.archives.gov/the-press-office/president-obama-appoints-dr-thomas-frieden-cdc-director
  27. https://www.congress.gov/116/meeting/house/110747/witnesses/HHRG-116-AP07-Bio-FriedenT-20200506.pdf
  28. https://pubmed.ncbi.nlm.nih.gov/12132002/
  29. https://www.scielosp.org/article/bwho/2002.v80n6/457-463/
  30. https://www.economist.com/asia/2002/06/20/joining-the-dots
  31. https://pmc.ncbi.nlm.nih.gov/articles/PMC1449302/
  32. https://pubmed.ncbi.nlm.nih.gov/15273972/
  33. https://ajph.aphapublications.org/doi/full/10.2105/AJPH.2004.058164
  34. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5624a4.htm
  35. https://publichealth.jhu.edu/2008/tom-frieden-lecture
  36. https://ajph.aphapublications.org/doi/10.2105/AJPH.2014.301940
  37. https://www.thelancet.com/article/S0140-6736%2810%2962122-8/fulltext
  38. https://a860-gpp.nyc.gov/downloads/kh04dq45x?locale=en
  39. https://www.nejm.org/doi/full/10.1056/NEJMp068153
  40. https://www.nature.com/articles/nm0406-378
  41. https://www.nytimes.com/2006/10/02/nyregion/federal-policy-calling-for-more-hiv-testing-poses-a-unique.html
  42. https://kffhealthnews.org/morning-breakout/dr00041846/
  43. https://www.nyclu.org/press-release/hiv-activists-tell-new-york-department-health-stop-gutting-informed-consent-laws
  44. https://www.poz.com/article/The-Frieden-Files-A-NY-Debate-on-Privacy-and-Testing-2921-6862
  45. https://pmc.ncbi.nlm.nih.gov/articles/PMC5508137/
  46. https://www.aclu.org/press-releases/hiv-activists-tell-new-york-department-health-stop-gutting-informed-consent-laws
  47. https://www.aclu.org/cases/challenge-change-new-york-hiv-testing-policy
  48. https://pmc.ncbi.nlm.nih.gov/articles/PMC1602014/
  49. https://news.yale.edu/2006/09/26/new-york-city-bans-trans-fats-restaurants
  50. https://www.nytimes.com/2006/12/06/nyregion/06fat.html
  51. https://www.latimes.com/archives/la-xpm-2006-dec-06-na-transfat6-story.html
  52. https://www.democracynow.org/2006/12/6/headlines/new_york_city_bans_trans_fats_in_restaurants_fast_food_chains
  53. https://www.nejm.org/doi/full/10.1056/NEJMp078058
  54. https://www.nature.com/articles/nm0206-155a
  55. https://pmc.ncbi.nlm.nih.gov/articles/PMC2881457/
  56. https://pmc.ncbi.nlm.nih.gov/articles/PMC2509589/
  57. https://www.npr.org/transcripts/5151660?storyId=5151660
  58. https://www.nejm.org/doi/abs/10.1056/NEJMp068008
  59. https://www.cdc.gov/pcd/issues/2008/apr/07_0053.htm
  60. https://www.sciencedirect.com/science/article/pii/S0735109709025121
  61. https://www.tctmd.com/news/trans-fat-ban-led-tangible-cvd-benefits-new-york-state-analysis-shows
  62. https://jamanetwork.com/journals/INTEMED/articlepdf/414161/icn70001_799_802.pdf
  63. https://www.jstor.org/stable/10.7758/9781610447089
  64. https://www.cdc.gov/pcd/issues/2009/jul/pdf/08_0215.pdf
  65. https://ssir.org/books/reviews/entry/only_in_new_york
  66. https://www.cuimc.columbia.edu/news/columbia-alumnus-dr-thomas-frieden-named-cdc-director-president-obama
  67. https://subscriber.politicopro.com/article/eenews/2009/05/15/nyc-health-commissioner-picked-to-lead-agency-187886
  68. https://pmc.ncbi.nlm.nih.gov/articles/PMC7137788/
  69. https://www.nbcnews.com/health/health-news/cdc-chief-picks-6-winnable-battles-health-flna1c9476613
  70. https://archive.cdc.gov/www_cdc_gov/media/releases/2016/p1205-winnable-battles.html
  71. https://www.fic.nih.gov/News/GlobalHealthMatters/july-august-2014/Pages/cdc-global-health-tom-frieden.aspx
  72. https://www.cdc.gov/mmwr/volumes/65/su/su6503a2.htm
  73. https://obamawhitehouse.archives.gov/blog/2014/10/15/heres-what-you-need-know-about-our-response-ebola-right-now
  74. http://res.dallasnews.com/interactives/duncan-timeline/
  75. https://cdcmuseum.org/exhibits/show/ebola/ebola-us/cdcrole
  76. https://www.bbc.com/news/world-us-canada-29590832
  77. https://www.cnn.com/2014/10/14/health/cdc-frieden-facing-criticism
  78. https://www.politico.com/story/2014/10/ebola-us-border-111581
  79. https://www.cbsnews.com/news/u-s-health-officials-in-opposition-to-ebola-travel-ban/
  80. https://archive.cdc.gov/www_cdc_gov/h1n1flu/cdcresponse.htm
  81. https://archive.cdc.gov/www_cdc_gov/h1n1flu/yearinreview.htm
  82. https://www.cbsnews.com/news/h1n1-most-dangerous-to-young-people/
  83. https://www.cidrap.umn.edu/h1n1-2009-pandemic-influenza/h1n1-lessons-learned-vaccination-campaign-weathered-rough-road-paid
  84. https://archive.cdc.gov/www_cdc_gov/media/releases/2016/p1230-highlighting-contributions-zika.html
  85. https://jamanetwork.com/journals/jama/fullarticle/2543301
  86. https://archive.cdc.gov/www_cdc_gov/media/releases/2016/p0902-cdc-colombia-collaboration.html
  87. https://pmc.ncbi.nlm.nih.gov/articles/PMC5132420/
  88. https://www.politico.com/states/florida/story/2016/08/scotts-criticisms-of-cdc-dont-hold-weight-with-public-health-officials-105046
  89. https://www.cdc.gov/mmwr/volumes/65/rr/rr6501e1.htm
  90. https://www.cdc.gov/mmwr/volumes/65/rr/pdfs/rr6501e1.pdf
  91. https://www.nejm.org/doi/full/10.1056/NEJMp1515917
  92. https://searchlf.ama-assn.org/undefined/documentDownload?uri=%252Funstructured%252Fbinary%252Fletter%252FLETTERS%252Fcdc-opioid-guidelines-12jan2016.pdf
  93. https://www.facebook.com/MadiganHealth/posts/as-you-may-know-our-nation-is-currently-in-an-opioidcrisis-with-approximately-11/10156394447351351/
  94. https://www.science.org/content/article/new-chief-orders-cdc-cut-management-layers
  95. https://www.washingtonpost.com/national/cdc-director-worries-about-impact-of-budget-cuts/2011/06/15/AGOVAqXH_story.html
  96. https://harris.house.gov/media/press-releases/congressman-harris-confronts-cdc-director-over-misleading-white-house
  97. https://www.science.org/content/article/cdcs-pinched-budget-focuses-chronic-disease-prevention
  98. https://www.nytimes.com/2014/07/17/us/cdc-director-admits-to-pattern-of-unsafe-practices.html
  99. https://www.science.org/content/article/lab-incidents-lead-safety-crackdown-cdc
  100. https://www.nature.com/articles/nature.2015.17176
  101. https://www.cidrap.umn.edu/biosecurity-issues/review-panel-finds-cdc-weak-lab-safety
  102. https://www.cnn.com/2015/12/14/health/cdc-frieden-gun-research
  103. https://www.nytimes.com/2018/03/12/health/gun-violence-research-cdc.html
  104. https://resolvetosavelives.org/who-we-are/about/
  105. https://resolvetosavelives.org/about/team/dr-tom-frieden/
  106. https://www.devex.com/organizations/resolve-to-save-lives-205002
  107. https://www.vitalstrategies.org/resolve-to-save-lives-announces-us-2-3-million-in-grants-to-promote-heart-health-in-low-and-middle-income-countries/
  108. https://extranet.who.int/sph/resolve-save-lives
  109. https://sph.unc.edu/cphm/resolve-to-save-lives-can-policies-in-the-u-s-and-other-countries-make-us-safer/
  110. https://resolvetosavelives.org/about/press/links-grant-awards-2021/
  111. https://resolvetosavelives.org/wp-content/uploads/2024/10/Transforming-Global-Cardiovascular-Health_Resolve-to-Save-Lives-and-World-Health-Organization.pdf
  112. https://pmc.ncbi.nlm.nih.gov/articles/PMC8031351/
  113. https://www.paho.org/en/partnerships/resolve-save-lives-cardiovascular-health-americas
  114. https://www.jacc.org/doi/10.1016/j.jacc.2023.08.043
  115. https://www.nature.com/articles/s41371-022-00745-2
  116. https://world-heart-federation.org/news/whf-partners-with-resolve-to-save-lives-to-promote-new-whos-hypertension-guidelines/
  117. https://www.vitalstrategies.org/covid-19-could-have-been-contained-new-report-shows-how-countries-successfully-beat-infectious-disease-outbreaks-before-they-became-epidemics/
  118. https://resolvetosavelives.org/
  119. https://resolvetosavelives.org/strategies-in-action/epidemic-preparedness-and-response-in-senegal/
  120. https://www.paho.org/en/news/25-7-2025-paho-and-resolve-save-lives-partner-epidemic-preparedness-americas
  121. https://resolvetosavelives.org/how-we-save-lives/epidemic-prevention/
  122. https://heart.bmj.com/content/110/17/1090
  123. https://resolvetosavelives.org/who-we-are/funding-partners/
  124. https://resolvetosavelives.org/wp-content/uploads/2025/04/497_CVH_Behind-the-Numbers-Measured-Impact_Fact-Sheet_0425_Rev-F_v5.pdf
  125. https://projects.propublica.org/nonprofits/organizations/862254152
  126. https://ncdalliance.org/resolve-to-save-lives
  127. https://pmc.ncbi.nlm.nih.gov/articles/PMC9009360/
  128. https://www.nature.com/articles/s41591-022-01890-4
  129. https://globalizationandhealth.biomedcentral.com/articles/10.1186/s12992-024-01080-6
  130. https://www.theatlantic.com/health/archive/2013/11/the-trans-fat-ban-as-science-policy-lag/281299/
  131. https://pmc.ncbi.nlm.nih.gov/articles/PMC6124688/
  132. https://www.hhs.gov/sites/default/files/consequences-smoking-exec-summary.pdf
  133. https://www.npr.org/sections/health-shots/2013/12/27/257646680/new-york-citys-bloomberg-leaves-mixed-results-on-health
  134. https://www.nytimes.com/2009/04/09/health/09soda.html
  135. https://www.reuters.com/article/world/uk/new-york-city-health-commissioner-scold-or-lifesaver-idUSBRE88004P/
  136. https://www.nbcnews.com/healthmain/nutrition-experts-despite-ruling-soda-ban-still-great-idea-1c8816720
  137. https://www.reuters.com/article/business/healthcare-pharmaceuticals/battle-lines-drawn-over-soda-junk-food-taxes-idUSTRE5806E5/
  138. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm63e1114a5.htm
  139. https://www.nytimes.com/2014/10/15/us/cdc-says-it-should-have-responded-more-quickly-to-dallas-ebola-case.html
  140. https://www.reuters.com/article/business/healthcare-pharmaceuticals/us-cdc-head-criticized-for-blaming-protocol-breach-as-nurse-gets-ebola-idUSKCN0I2067/
  141. https://www.cbsnews.com/news/ebola-virus-response-in-dallas-had-mistakes-cdc-admits/
  142. https://www.theguardian.com/world/2014/oct/16/texas-hospital-sorry-ebola-case-errors
  143. https://www.c-span.org/program/house-committee/us-response-to-ebola/371200
  144. https://www.congress.gov/event/113th-congress/house-event/LC25268/text
  145. https://www.statnews.com/2018/08/24/former-cdc-director-tom-frieden-arrested-on-sexual-misconduct-charges/
  146. https://www.cnn.com/2018/08/24/health/frieden-cdc-arrest-forcibly-touching
  147. https://www.nytimes.com/2018/08/24/nyregion/thomas-frieden-arrest-cdc.html
  148. https://www.politico.com/story/2018/08/24/tom-frieden-cdc-arrest-sex-abuse-795490
  149. https://www.nbcnews.com/news/us-news/former-cdc-director-dr-tom-frieden-arrested-sexual-misconduct-allegations-n903586
  150. https://www.theguardian.com/us-news/2018/aug/24/former-cdc-director-thomas-frieden-arrested-on-sex-abuse-charge
  151. https://www.wsj.com/articles/former-cdc-head-pleads-guilty-in-sexual-misconduct-case-11559669119
  152. https://www.fox5atlanta.com/news/former-head-of-the-cdc-pleads-guilty-to-violation
  153. https://pmc.ncbi.nlm.nih.gov/articles/PMC4984754/
  154. https://pmc.ncbi.nlm.nih.gov/articles/PMC2836340/
  155. https://simpledotorg.gitbook.io/dr-tom-frieden-public-health
  156. https://www.amazon.com/Books-Thomas-R-Frieden/s?rh=n%253A283155%252Cp_27%253AThomas%252BR.%252BFrieden
  157. https://www.covidcollaborative.us/team/tom-frieden
  158. https://mitpress.mit.edu/9780262050968/the-formula-for-better-health/
  159. https://www.pbs.org/newshour/show/former-cdc-director-offers-an-insiders-formula-for-better-health-in-new-book
  160. https://erictopol.substack.com/p/tom-frieden-and-eric-topol-discuss
  161. https://mitpress.mit.edu/featured-book-the-formula-for-better-health-by-tom-frieden-md-mph/
  162. https://resolvetosavelives.org/about/press/statement-from-dr-tom-frieden-president-and-ceo-of-resolve-to-save-lives-on-u-s-withdrawal-from-who/
  163. https://www.lemonde.fr/en/opinion/article/2025/09/22/tom-frieden-former-cdc-director-the-us-is-dismantling-its-own-health-infrastructure-and-retreating-from-global-health-leadership_6745625_23.html
  164. https://resolvetosavelives.org/about/press/tom-frieden-statement-cdc-cuts/
  165. https://opentodebate.org/debate/was-covid-a-public-health-failure-or-did-society-fail-public-health/
  166. https://harvardpublichealth.org/policy-practice/elias-zerhouni-and-tom-frieden-on-public-health-under-rfk-jr/
  167. https://www.nydailynews.com/2018/08/24/former-city-health-commissioner-thomas-frieden-kind-of-apologized-after-alleged-grope-victim/
  168. https://www.huffpost.com/entry/tom-frieden-sexual-misconduct-arrested_n_5b802c24e4b0729515128be4
  169. https://www.statnews.com/2018/08/26/thomas-frieden-arrest-imperils-legacy-and-global-health-campaign/
  170. https://www.nytimes.com/2010/03/16/health/16prof.html
  171. https://www.facebook.com/CDC/photos/cdc-director-dr-tom-frieden-takes-mens-health-along-on-his-275-mile-father-son-c/10152292747476026/
  172. https://www.aarp.org/advocacy/talking-with-cdc-director-tom-frieden-2016/
  173. https://www.linkedin.com/posts/tom-frieden_physical-activity-is-the-closest-thing-we-activity-7254156165784219648-LYT8
  174. https://x.com/DrTomFrieden/status/1340050678580953088
  175. https://www.cnn.com/2020/02/22/health/heart-disease-us-frieden-wellness
Add your contribution
Related Hubs
User Avatar
No comments yet.